FDA Drug Recalls

Recalls / Class II

Class IID-0393-2019

Product

Epinephrine liquid 1:1000, RX, glass vial

Affected lot / code info
10102018@13 exp 1/8/19, 10222018@33 exp 1/20/19,

Why it was recalled

Lack of sterility assurance.

Recalling firm

Firm
Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1350 Ne Stephens St Ste 42, N/A, Roseburg, Oregon 97470-6410

Distribution

Quantity
50 ml
Distribution pattern
Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.

Timeline

Recall initiated
2019-01-02
FDA classified
2019-01-27
Posted by FDA
2019-01-09
Terminated
2023-03-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0393-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls